Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Low RiskFDA Drug
Medications & Supplements/Prescription Drugs

Akorn Inc: Fentanyl Citrate Injection Recalled Due to Excessive Impurities

Agency Publication Date: April 1, 2020
Share:
Sign in to monitor this recall

Summary

Akorn Inc. has voluntarily recalled 15,170 ampules of Fentanyl Citrate Injection, USP (100 mcg/2 mL). This recall was issued because laboratory testing found that the total impurity level in the medication was 4.1%, which is higher than the approved safety limit of 3.0%. About 15,170 units are affected by this issue, which was discovered during routine testing of retained samples. Consumers should contact their doctor or pharmacist regarding any products from the affected lot, as the degradation of the medication may impact its performance.

Risk

The presence of impurities above the specified limit means the drug has degraded more than allowed, which could potentially result in reduced effectiveness or unexpected side effects for the patient.

What You Should Do

  1. Check your medication to see if you have Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL) in 2 mL ampules.
  2. Verify if your product is affected by looking for NDC 17478-030-02 and Lot 081887A with an expiration date of 08/2021 on the carton or ampule.
  3. If you have the affected product, contact your healthcare provider or pharmacist for guidance on whether you should continue use or seek an alternative.
  4. Return any unused product from Lot 081887A to the pharmacy where it was purchased for a refund.
  5. Contact Akorn Inc. directly at their Lake Forest, Illinois office for further instructions on returning the product and receiving credit.
  6. For additional questions or to report a problem, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

๐Ÿ’ฐFull Refund

Healthcare provider consultation and pharmacy refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund.

Affected Products

Product: Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 10 Ampules per carton
Model:
NDC 17478-030-02
Lot Numbers:
081887A (Exp 08/2021)
Date Ranges: Exp 08/2021

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 85239
Status: Resolved
Manufacturer: Akorn Inc
Sold By: pharmacies; hospitals
Manufactured In: United States
Units Affected: 15,170 ampules
Distributed To: Nationwide
Agency Last Updated: May 1, 2020

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.